Page last updated: 2024-08-21

congo red and Nerve Degeneration

congo red has been researched along with Nerve Degeneration in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's5 (50.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crowther, DC; Curry, JA; Duthie, FA; Gubb, DC; Kinghorn, KJ; Lomas, DA; Miranda, E; Page, R1
Bose, M; Crabtree, GR; Devasthali, V; Gestwicki, JE; Graef, IA1
Davidowitz, E; Evgen'ev, M; Grossman, A; Korochkin, L; Medvedeva, A; Moe, JG; Myasnyankina, E; Nikitina, E; Peresleni, A; Popov, A; Pyatkov, K; Savvateeva-Popova, E; Schostak, N; Zatsepina, O; Zelentsova, E1
Lorenzo, A; Yankner, BA2
Kitamoto, T; Kondo, A; Ogino, K; Saido, TC; Shin, RW; Tateishi, J; Trojanowski, JQ1
Emmerling, MR; Spiegel, K; Watson, MD1
Dutton, NS; Kakulas, BA; Martins, RN; Papadimitriou, JM; Robertson, TA; Roses, AD1
Bian, F; Callahan, MJ; Durham, RA; Kane, MD; Lipinski, WJ; Roher, AE; Schwarz, RD; Walker, LC1
Gibson, PH1

Reviews

2 review(s) available for congo red and Nerve Degeneration

ArticleYear
'Nature-inspired' drug-protein complexes as inhibitors of Abeta aggregation.
    Biochemical Society transactions, 2005, Volume: 33, Issue:Pt 4

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Congo Red; Humans; Multiprotein Complexes; Nerve Degeneration; Tacrolimus Binding Proteins

2005
Amyloid fibril toxicity in Alzheimer's disease and diabetes.
    Annals of the New York Academy of Sciences, 1996, Jan-17, Volume: 777

    Topics: Alzheimer Disease; Amyloid; Animals; Cats; Cells, Cultured; Congo Red; Diabetes Mellitus; Hippocampus; Humans; Islet Amyloid Polypeptide; Islets of Langerhans; Nerve Degeneration; Neurons; Rats; Solubility; Synapses

1996

Other Studies

8 other study(ies) available for congo red and Nerve Degeneration

ArticleYear
Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
    Neuroscience, 2005, Volume: 132, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Congo Red; Disease Models, Animal; Drosophila melanogaster; Inclusion Bodies; Longevity; Movement Disorders; Nerve Degeneration; Nervous System; Neurons; Neuroprotective Agents; Peptide Fragments; Transgenes; Vacuoles

2005
Pathogenic chaperone-like RNA induces congophilic aggregates and facilitates neurodegeneration in Drosophila.
    Cell stress & chaperones, 2007,Spring, Volume: 12, Issue:1

    Topics: Animals; Animals, Genetically Modified; Brain; Cell Survival; Congo Red; Cytoplasm; Drosophila melanogaster; Gene Expression Regulation; Heat-Shock Response; Larva; Longevity; Male; Memory; Molecular Chaperones; Nerve Degeneration; Protein Structure, Quaternary; RNA, Untranslated; Salivary Glands

2007
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Dec-06, Volume: 91, Issue:25

    Topics: Amyloid; Amyloid beta-Peptides; Animals; Cells, Cultured; Congo Red; Dose-Response Relationship, Drug; Hippocampus; Islet Amyloid Polypeptide; Islets of Langerhans; Nerve Degeneration; Neurons; Neurotoxins; Rats; Structure-Activity Relationship; Synapses

1994
Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, Nov-01, Volume: 17, Issue:21

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Birefringence; Cerebral Cortex; Coloring Agents; Congo Red; Endopeptidases; Female; Hippocampus; Humans; Injections; Microscopy, Electron; Nerve Degeneration; Nerve Tissue Proteins; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Sprague-Dawley

1997
Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Immunopharmacology, 1997, Volume: 38, Issue:1-2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Coloring Agents; Complement Activation; Complement C1 Inactivator Proteins; Complement C1q; Complement C3-C5 Convertases; Complement C3a; Complement C4; Congo Red; Egtazic Acid; Humans; Nerve Degeneration; Protease Inhibitors

1997
Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice.
    Neuroscience, 1998, Volume: 82, Issue:1

    Topics: Aging; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Apolipoproteins E; Brain; Coloring Agents; Congo Red; Female; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Microscopy, Electron; Nerve Degeneration

1998
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, May-15, Volume: 20, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigen-Antibody Reactions; Cerebral Arteries; Coloring Agents; Congo Red; Disease Models, Animal; Encephalitis; Female; Hippocampus; Humans; Injections, Intraventricular; Male; Mice; Mice, Transgenic; Nerve Degeneration

2000
Relationship between numbers of cortical argentophilic and congophilic senile plaques in the brains of elderly people with and without senile dementia of Alzheimer type.
    Gerontology, 1985, Volume: 31, Issue:5

    Topics: Aged; Alzheimer Disease; Amyloidosis; Cerebral Cortex; Congo Red; Humans; Nerve Degeneration; Neurofibrils; Neurons

1985